Associations between anemia and FGF23 in the CKiD study

Background Fibroblast growth factor 23 (FGF23) is a bone-derived hormone that plays a central role in chronic kidney disease-mineral bone disorder and is associated with CKD progression and cardiovascular morbidity. Factors related to CKD-associated anemia, including iron deficiency, can increase FGF23 production. This study aimed to assess whether anemia and/or iron deficiency are associated with increased circulating concentrations of FGF23 in the large, well-characterized Chronic Kidney Disease in Children (CKiD) study cohort. Methods Hemoglobin concentrations, iron parameters, C-terminal (total) FGF23, intact FGF23, and relevant covariables were measured in cross-sectional analysis of CKiD study subjects. Results In 493 pediatric patients with CKD (median [interquartile range] age 13 [9, 16] years), the median estimated glomerular filtration rate was 48 [35, 61] ml/min/1.73 $ m^{2} $, and 103 patients (21%) were anemic. Anemic subjects had higher total FGF23 concentrations than non-anemic subjects (204 [124, 390] vs. 109 [77, 168] RU/ml, p < 0.001). In multivariable linear regression modeling, anemia was independently associated with higher total FGF23, after adjustment for demographic, kidney-related, mineral metabolism, and inflammatory covariables (standardized β (95% confidence interval) 0.10 (0.04, 0.17), p = 0.002). In the subset of subjects with available iron parameters (n = 191), iron deficiency was not associated with significantly higher total FGF23 concentrations. In the subgroup that had measurements of both total and intact FGF23 (n = 185), in fully adjusted models, anemia was significantly associated with higher total FGF23 (standardized β (95% CI) 0.16 (0.04, 0.27), p = 0.008) but not intact FGF23 (standardized β (95% CI) 0.02 (−0.12, 0.15), p = 0.81). Conclusions In this cohort of pediatric patients with CKD, anemia was associated with increased total FGF23 levels but was not independently associated with elevated intact FGF23, suggesting possible effects on both FGF23 production and cleavage. Further studies are warranted to investigate non-mineral factors affecting FGF23 production and metabolism in CKD. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information.

Medienart:	E-Artikel

Erscheinungsjahr:	2023
Erschienen:	2023

Enthalten in:	Zur Gesamtaufnahme - volume:39
Enthalten in:	Pediatric nephrology - 39(2023), 3 vom: 26. Sept., Seite 837-847

Sprache:	Englisch

Beteiligte Personen:	Thomas, Elizabeth [VerfasserIn] Klomhaus, Alexandra M. [VerfasserIn] Laster, Marciana L. [VerfasserIn] Furth, Susan L. [VerfasserIn] Warady, Bradley A. [VerfasserIn] Salusky, Isidro B. [VerfasserIn] Hanudel, Mark R. [VerfasserIn]

Links:	Volltext [kostenfrei]

Themen:	Anemia Chronic kidney disease Fibroblast growth factor 23 Iron Pediatrics

Anmerkungen:	© The Author(s) 2023

doi:	10.1007/s00467-023-06160-0

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	SPR054533201